Literature DB >> 13394580

Serum isoniazid levels and catalase activities of tubercle bacilli from isoniazid-treated patients.

M L COHN, W MANDEL, G MIDDLEBROOK, W F RUSSELL.   

Abstract

Entities:  

Keywords:  CATALASE/determination; ISONIAZID/in blood; TUBERCULOSIS/blood in

Mesh:

Substances:

Year:  1957        PMID: 13394580     DOI: 10.1097/00000441-195701000-00011

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  6 in total

1.  Combined drug treatment of tuberculosis. IV. Bacteriologic studies on the sputum and resected pulmonary lesions of tuberculous patients.

Authors:  A D HEATON; W F RUSSELL; J DENST; G MIDDLEBROOK
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  Combined drug treatment of tuberculosis. II. Studies of antimicrobially-active isoniazid and streptomycin serum levels in adult tuberculous patients.

Authors:  W MANDEL; A D HEATON; W F RUSSELL; G MIDDLEBROOK
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

3.  Combined drug treatment of tuberculosis. III. Clinical application of the principles of appropriate and adequate chemotherapy to the treatment of pulmonary tuberculosis.

Authors:  W F RUSSELL; I KASS; A D HEATON; S H DRESSLER; G MIDDLEBROOK
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

4.  Isoniazid- and ethambutol-induced psychosis.

Authors:  R Prasad; Rajiv Garg; Sanjay Kumar Verma
Journal:  Ann Thorac Med       Date:  2008-10       Impact factor: 2.219

5.  Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis.

Authors:  P R GANGADHARAM; A L BHATIA; S RADHAKRISHNA; J B SELKON
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

6.  Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. 2. Clinical implications in the treatment of pulmonary tuberculosis with isoniazid either alone or in combination with PAS.

Authors:  J B SELKON; W FOX; P R GANGADHARAM; K RAMACHANDRAN; C V RAMAKRISHNAN; S VELU
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.